摘要
目的探讨前列腺增生合并膀胱癌一期手术安全性与疗效,以及与膀胱癌复发的影响。方法对42例前列腺增生合并膀胱癌患者,行膀胱部分切除术和前列腺摘除术的临床资料进行回顾性分析。结果所有病例术后均排尿通畅,残余尿<15ml,36例获得随访,随访时间2～6年,复发率为16.7%。所有复发病例再次手术发现肿瘤部位不在前列腺窝或膀胱颈处。结论前列腺增生症致尿路梗阻是膀胱癌复发的重要因素,对膀胱癌合并前列腺增生症致尿路梗阻者,解除梗阻可降低膀胱癌的复发率;同期手术是安全和有益的。
Objective To study the safety and the result of open surgery for BPH with bladder transitional cell carcinoma. Meth. ods The clinical data of 42 cases of patients with BPH and blader transitional cell carcinoma were retrospectively reviewed. All the patients were taken measures of partial bladder resect and prostatectomy. Results All the patients urinated fluently, and the residual urine was less than 15 mi. The follow - up period ranged from two to six years. The proportion of bladder transitional cell carcinoma recurrence was 16.7%, and the implantation of the tumor to the prostatic bed or bladder neck was not been found. Conclusion Urethremphraxis （ urinary tract obstruction） is an important cause of blader transitional cell carcinoma recurrence. To relieve it could decrease bladder carcinoma recurrence. Open surgery for BPH with bladder transitional cell carcinoma is safe and beneficial.
出处
《临床军医杂志》
CAS
2005年第5期570-572,共3页
Clinical Journal of Medical Officers
关键词
前列腺增生
膀胱肿瘤
复发
prostatic hyperplasia
blader transitional cell carcinoma
recurrence
